Hester Biosciences logo
524669 logo

Hester BiosciencesBSE:524669 Stock Report

Market Cap ₹16.7b
Share Price
n/a
1Y33.6%
7D-10.1%
Portfolio Value
​
View

Hester Biosciences Limited

BSE:524669 Stock Report

Market Cap: ₹16.7b

524669 Stock Overview

Manufactures and trades in veterinary vaccines and animal health products in India and internationally. More details

524669 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health3/6
Dividends4/6

Rewards

Price-To-Earnings ratio (53.7x) is below the Biotechs industry average (53.9x)

Risk Analysis

Earnings have declined by 8.4% per year over past 5 years

Has a high level of debt

Unstable dividend track record


My Notes

Capture your thoughts, links and company narrative

Hester Biosciences Limited Competitors

Zenotech Laboratories

BSE:532039

₹3.7b

Nirman Agri Genetics

NSEI:NIRMAN

₹2.1b

Biocon

NSEI:BIOCON

₹433.9b

SMS Pharmaceuticals

NSEI:SMSPHARMA

₹17.1b

Price History & Performance

Summary of share price highs, lows and changes for Hester Biosciences
Historical stock prices
Current Share Price₹1,965.55
52 Week High₹3,375.45
52 Week Low₹1,292.90
Beta0.73
1 Month Change-17.55%
3 Month Change-17.73%
1 Year Change33.57%
3 Year Change-20.33%
5 Year Change25.07%
Change since IPO47,073.21%

Recent News & Updates

Recent updates

Shareholder Returns

524669IN BiotechsIN Market
7D-10.1%-6.9%0.9%
1Y33.6%33.1%6.8%

Return vs Industry: 524669 matched the Indian Biotechs industry which returned 33.1% over the past year.

Return vs Market: 524669 exceeded the Indian Market which returned 6.8% over the past year.

Price Volatility

Is 524669's price volatile compared to industry and market?
524669 volatility
524669 Average Weekly Movement5.0%
Biotechs Industry Average Movement6.3%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 524669 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 524669's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987642Rajiv Gandhiwww.hester.in

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, marek’s disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis.

Hester Biosciences Limited Fundamentals Summary

How do Hester Biosciences's earnings and revenue compare to its market cap?
524669 fundamental statistics
Market cap₹16.72b
Earnings (TTM)₹311.47m
Revenue (TTM)₹3.19b

53.7x

P/E Ratio

5.2x

P/S Ratio

Is 524669 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524669 income statement (TTM)
Revenue₹3.19b
Cost of Revenue₹929.73m
Gross Profit₹2.26b
Other Expenses₹1.95b
Earnings₹311.47m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)36.61
Gross Margin70.90%
Net Profit Margin9.75%
Debt/Equity Ratio77.7%

How did 524669 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

27%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 22:47
End of Day Share Price 2025/01/31 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hester Biosciences Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vaishali Kumar ParkarBOB Capital Markets Ltd.
Kameswari V. S. ChavaliFirstCall Research
Siddhant KhandekarICICIdirect.com